Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hum Reprod ; 19(11): 2561-8, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15471924

RESUMO

BACKGROUND: The aim of this study was to evaluate the functional characteristics of granulosa cell populations of individual follicles of women undergoing controlled ovarian stimulation (COS) for IVF/ICSI in whom gonadotrophin had been withheld ('coasted') for the prevention of OHSS. METHODS: Follicular fluid and granulosa cells were isolated from 224 individual follicles in 41 women who had been coasted and from 257 individual follicles in 50 women who had a 'normal' response to COS. Cells were cultured at 10,000 cells per well, to evaluate progesterone secretion. Follicular fluid was assayed for progesterone and estradiol (E2). RESULTS: No significant differences were observed between the two groups with respect to granulosa cell number or follicular fluid progesterone and E2 and follicle size, the retrieval of an oocyte and the subsequent fertilization of the oocyte. However, the granulosa cells derived from the coasted group showed a higher rate of progesterone secretion per cell at 72 h which was sustained for longer. Differences were also seen at 72 and 120 h of culture with a loss of correlation between progesterone secretion and follicle diameter in the coasted group. CONCLUSIONS: Our findings suggest that coasting has an effect on the functional capacity of the granulosa cells and the duration of their function. It is likely that in women at risk of OHSS who are not coasted, the granulosa cells have the capacity to produce significantly more chemical mediators per cell and for a more prolonged period of time.


Assuntos
Gonadotropinas/uso terapêutico , Células da Granulosa/citologia , Síndrome de Hiperestimulação Ovariana/prevenção & controle , Indução da Ovulação/métodos , Adulto , Estudos de Casos e Controles , Tamanho Celular , Células Cultivadas , Estradiol/análise , Feminino , Fertilização in vitro/métodos , Líquido Folicular/metabolismo , Humanos , Fase Luteal , Oócitos/citologia , Oócitos/fisiologia , Folículo Ovariano/citologia , Folículo Ovariano/fisiologia , Gravidez , Taxa de Gravidez , Progesterona/análise
2.
Hum Reprod ; 19(3): 522-8, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-14998945

RESUMO

BACKGROUND: The aim of this study was to assess the effect of withholding gonadotrophins (coasting) during controlled ovarian stimulation (COS) on individual follicle concentrations of follicular fluid vascular endothelial growth factor (VEGF) in women at high risk of developing ovarian hyperstimulation syndrome (OHSS). METHODS: Twenty-two women who had been coasted and 26 optimally responding women (control group) undergoing COS for IVF were studied. At the time of oocyte retrieval, the follicular fluid from four to six individual follicles of different sizes was collected for VEGF analysis. RESULTS: A total of 118 follicles was analysed in the coasted group and 137 in the control group. A negative correlation was observed between the follicle size and VEGF concentration (r = -0.18, P = 0.03) in the control group, which was not seen in the coasted group. Similarly, the correlation between oestradiol (E(2)) and VEGF (r = 0.4, P < 0.0001) observed in the control group was not apparent in the coasted group. Significantly lower concentrations of VEGF were seen in the follicular fluid of the coasted patients. CONCLUSIONS: It is clear that there are differences in follicular fluid VEGF concentrations between the two groups. It is possible that coasting alters the capacity of the granulosa cells to produce VEGF and/or their response to hCG and in this way acts to reduce the severity and incidence of severe OHSS.


Assuntos
Líquido Folicular/metabolismo , Gonadotropinas/administração & dosagem , Folículo Ovariano/metabolismo , Síndrome de Hiperestimulação Ovariana/prevenção & controle , Indução da Ovulação/efeitos adversos , Fator A de Crescimento do Endotélio Vascular/metabolismo , Adulto , Contagem de Células , Esquema de Medicação , Embrião de Mamíferos/fisiologia , Estradiol/metabolismo , Feminino , Fertilização in vitro , Células da Granulosa/citologia , Humanos , Oócitos , Tamanho do Órgão , Concentração Osmolar , Folículo Ovariano/anatomia & histologia , Síndrome de Hiperestimulação Ovariana/etiologia , Síndrome de Hiperestimulação Ovariana/fisiopatologia , Progesterona/metabolismo , Fatores de Risco , Coleta de Tecidos e Órgãos
3.
Hum Reprod ; 19(1): 107-9, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14688166

RESUMO

A suspected poor responder to controlled ovarian stimulation (COS), with menopausal levels of follicular phase serum FSH, required coasting due to an excessive ovarian response. A 27 year old woman was referred to our Fertility Centre for ovum donation following repeated elevated, early follicular phase FSH levels (34.3, 27.1, 20.3 IU/l). Further investigations revealed the presence of antiovarian antibodies and a trial of COS, with the additional use of prednisolone, was proposed in view of her regular 28 day cycle. As 23 follicles were noted and an oestradiol level of 10,461 pmol/l following 7 days of stimulation with 450 IU of recombinant FSH per day, gonadotrophins were withheld for 9 days. Ten oocytes were retrieved and two grade I embryos were transferred. Pregnancy did not occur and she developed mild ovarian hyperstimulation syndrome. During a second cycle, multiple follicular development was again observed with an oestradiol level >13,200 pmol/l, despite a lower dose of gonadotrophin, and coasting was required for 4 days. Nineteen oocytes were collected, of which nine fertilized and cleaved. Two grade I embryos were replaced, leading to a singleton pregnancy. This patient subsequently had a vaginal delivery of a normal male baby at term. Young women with regular menstrual cycles and grossly elevated FSH levels may benefit from further investigation of autoantibodies and their ovarian response to exogenous gonadotrophins.


Assuntos
Hormônio Foliculoestimulante/sangue , Infertilidade Feminina/tratamento farmacológico , Infertilidade Feminina/fisiopatologia , Menopausa/sangue , Folículo Ovariano/fisiopatologia , Indução da Ovulação , Adulto , Parto Obstétrico , Transferência Embrionária , Feminino , Fertilização in vitro , Hormônio Foliculoestimulante/efeitos adversos , Hormônio Foliculoestimulante/uso terapêutico , Humanos , Recém-Nascido , Infertilidade Feminina/sangue , Masculino , Oócitos , Folículo Ovariano/efeitos dos fármacos , Síndrome de Hiperestimulação Ovariana/induzido quimicamente , Indução da Ovulação/efeitos adversos , Gravidez , Proteínas Recombinantes/efeitos adversos , Proteínas Recombinantes/uso terapêutico , Coleta de Tecidos e Órgãos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...